clinical trial · NCT05337124
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
Lupus NephritisLUPKYNIS
brief summary
This registry is an observational study designed to assess the utilization and effectiveness of LUPKYNIS in adult patients with lupus nephritis (LN) in the United States (US).
started
Apr 5, 2022
primary completion
Jan 31, 2025
completion
Jan 31, 2025
last updated
Jun 24, 2025
detailed description
This registry is an observational study designed to assess the utilization and effectiveness of LUPKYNIS in patients with lupus nephritis (LN) in the United States (US). This registry is intended to benefit and support interests of patients, clinicians, regulatory bodies, payers, and industry by obtaining longitudinal data on LUPKYNIS.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol